SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Wednesday reported a loss of $52.8 million in its second quarter.
The San Diego-based company said it had a loss of $2.02 per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.91 per share.
The drugmaker posted revenue of $1.6 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $2.5 million.
La Jolla Pharmaceutical shares have climbed almost 2 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $32.79, an increase of 1 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LJPC at https://www.zacks.com/ap/LJPC